A

Achilles Therapeutics plc

ACHL

0.79010
USD
-0.0249
(-3.06%)
Market Closed
Volume
228
EPS
0
Div Yield
0
P/E
-1
Market Cap
41,083,792
Related Instruments
A
AMC
-0.18500
(-3.48%)
5.12500 USD
C
-1.600
(-2.47%)
63.280 USD
H
H
-6.256
(-4.25%)
141.112 USD
L
L
-0.760
(-0.95%)
79.210 USD
News

Title: Achilles Therapeutics plc

Sector: Healthcare
Industry: Biotechnology
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.